Showing results (1461-1470 of 1,692) with videos related to
Sort By:
Pageof 170
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 8, 2016
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathyRobert Hoepner, Eva M Kolb, Stefanie Dahlhaus, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|August 9, 2016
Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder CancerR Leibowitz-Amit, A Israel, M Gal, et al.Epilepsia|January 1, 1995
Successful epilepsy surgery without intracranial EEG recording: criteria for patient selectionV M Thadani, P D Williamson, R Berger, et al.Oncogene|February 1, 1992
Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variantsJ H Tong, S Dong, J P Geng, et al.Journal of Inherited Metabolic Disease|January 1, 1983
Absence of hepatic molybdenum cofactor: an inborn error of metabolism leading to a combined deficiency of sulphite oxidase and xanthine dehydrogenaseS K Wadman, M Duran, F A Beemer, et al.Neurology|November 11, 2009
Determinants of survival in progressive multifocal leukoencephalopathyA Marzocchetti, T Tompkins, D B Clifford, et al.The Journal of Pathology. Clinical Research|February 9, 2018
IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasisMichael Zepp, Marineta Kovacheva, Munkhtsetseg Altankhuyag, et al.Journal of Inherited Metabolic Disease|March 7, 2013
An update on serine deficiency disordersS N van der Crabben, N M Verhoeven-Duif, E H Brilstra, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 20, 2015
Optimal Treatment of Retinal Vein Occlusion: Canadian Expert ConsensusAlan R Berger, Alan F Cruess, Filiberto Altomare, et al.Current Medical Research and Opinion|September 7, 2023
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosisHelmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, et al.Pageof 170